JW Lifescience Corporation (KRX:234080)

JW Lifescience Revenue

JW Lifescience had revenue of 62.61B KRW in the quarter ending September 30, 2025, with 8.04% growth. This brings the company's revenue in the last twelve months to 248.30B, up 12.19% year-over-year. In the year 2024, JW Lifescience had annual revenue of 222.48B with 7.55% growth.

• Revenue (ttm): 248.30B
• Revenue Growth: +12.19%
• P/S Ratio: 0.95
• Revenue / Employee: 836.02M
• Employees: 297
• Market Cap: 235.37B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	222.48B	15.62B	7.55%
Dec 31, 2023	206.86B	17.93B	9.49%
Dec 31, 2022	188.93B	19.11B	11.26%
Dec 31, 2021	169.82B	-13.70B	-7.47%
Dec 31, 2020	183.52B	13.30B	7.81%